MoonLake Immunotherapeutics | ARS: Annual Report to Security Holders
Apr 24 16:40 ET
MoonLake Immunotherapeutics | DEFA14A: Others
Apr 24 16:39 ET
MoonLake Immunotherapeutics | DEF 14A: Definitive information statements
Apr 24 16:35 ET
MoonLake Immunotherapeutics | 8-K: Current report
Mar 11 08:06 ET
MoonLake Immunotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF PARTNERS L.P.(34.6%),BVF INC.(34.6%), etc.
Mar 5 17:06 ET
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge
Feb 29 19:59 ET
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian
Feb 29 19:54 ET
MoonLake Immunotherapeutics | 10-K: Annual report
Feb 29 08:08 ET
MoonLake Immunotherapeutics | 8-K: Current report
Feb 29 08:08 ET
MoonLake Immunotherapeutics | 8-K: Current report
Feb 26 09:05 ET
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge
Feb 23 16:56 ET
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian
Feb 22 18:37 ET
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge
Feb 20 18:39 ET
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian
Feb 16 18:07 ET
MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 15 16:08 ET
MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Merck Healthcare KGaA, Darmstadt Germany an affiliate of Merck KGaA, Darmstadt, Germany(4.7%),Merck KGaA, Darmstadt, Germany(4.7%), etc.
Feb 15 08:07 ET
MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 14 18:08 ET
MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(3.4%),Citadel Advisors LLC(3.3%), etc.
Feb 14 17:04 ET
MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bihua Chen(14.17%)
Feb 14 15:10 ET
MoonLake Immunotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(6.419%),Abigail P. Johnson(6.419%)
Feb 9 09:34 ET
No Data
No Data